1. Ziętek M, Nowacki M, Wierzbicki J, et al. An analysis of clinical effectiveness of electrochemotherapy in the treatment of advanced metastatic malignant melanoma performed in the eastern part of Central Europe: a single-centre experience. Adv Dermatol Allergol 2022; 39: 559-64.
2.
Abbas O, Miller DD, Bhawan J. Cutaneous malignant melanoma: update on diagnostic and prognostic biomarkers. Am J Dermatopathol 2014; 36: 363-79.
3.
Zegarska B, Pietkun K, Zegarski W, et al. Air pollution, UV irradiation and skin carcinogenesis: what we know, where we stand and what is likely to happen in the future? Adv Dermatol Allergol 2017; 34: 6-14.
4.
Kandel M, Bardet A, Dalle S, et al. Cost-effectiveness analysis of sequential treatment strategies for advanced melanoma in real life in France. Curr Oncol 2022; 29: 9255-70.
5.
Johnston KM, McPherson E, Osenenko K, et al. Cost-effectiveness of therapies for melanoma. Expert Rev Pharmacoecon Outcomes Res 2015; 15: 229-42.
6.
Dorrell DN, Strowd LC. Skin cancer detection technology. Dermatol Clin 2019; 37: 527-36.
7.
Nowacki M, Alyami M, Villeneuve L, et al. Multicenter comprehensive methodological and technical analysis of 832 pressurized intraperitoneal aerosol chemotherapy (PIPAC) interventions performed in 349 patients for peritoneal carcinomatosis treatment: an international survey study. Eur J Surg Oncol 2018; 44: 991-6.
8.
Drageset J, Sandvik RK, Eide LSP, et al. Quality of life among cancer inpatients 80 years and older: a systematic review. Health Qual Life Outcomes 2021; 19: 98.
9.
Suarez-Almazor M, Pinnix C, Bhoo-Pathy N, et al. Quality of life in cancer care. Medicine 2021; 2: 885-8.
10.
Malkhasyan KA, Zakharia Y, Milhem M. Quality-of-life outcomes in patients with advanced melanoma: a review of the literature. Pigment Cell Melanoma Res 2017; 30: 511-20.
11.
Berning V, Heidegger T, Laupheimer M, Nübling M. Patient satisfaction and quality of recovery. Anaesthesia 2018; 73: 521-2.
12.
Gavurova B, Dvorsky J, Popesko B. Patient satisfaction determinants of inpatient healthcare. Int J Environ Res Public Health 2021; 18: 11337.
13.
Nowacki M, Zegarski W. The scientific report from the first pressurized intraperitoneal aerosol chemotherapy (PIPAC) procedures performed in the eastern part of Central Europe. J Int Med Res 2018; 46: 3748-58.
14.
Ziętek M, Wierzbicki J, Pawlak E, et al. Introduction of a pilot program to measure and improve the clinical care of melanoma patientsf in the Lower Silesian Voivodeship in Poland: a report of 20 months experience. BMC Cancer 2022; 22: 1207.
15.
Ziętek M, Zdzienicki M, Wierzbicki J, et al. Survival of patients with stage IIIC and IIID melanomas with nodal metastases in the light of new therapies. Adv Dermatol Alergoll 2022; 39: 1141-50.
16.
Jenkins RW, Fisher DE. Treatment of advanced melanoma in 2020 and beyond. J Invest Dermatol 2021; 141: 23-31.
17.
Wolchok JD, Chiarion-Sileni V, Gonzalez R, et al. Long-term outcomes with nivolumab plus ipilimumab or nivolumab alone versus ipilimumab in patients with advanced melanoma. J Clin Oncol 2022; 40: 127-37.
18.
Eibenberger K, Dunavoelgyi R, Gleiss A, et al. Hypofractionated stereotactic photon radiotherapy of choroidal melanoma: 20-year experience. Acta Oncol 2021; 60: 207-14.
19.
Cucu CI, Giurcăneanu C, Popa LG, et al. Electrochemotherapy and other clinical applications of electroporation for the targeted therapy of metastatic melanoma. Materials 2021; 14: 3985.
20.
Garbe C, Amaral T, Peris K, et al. European consensus-based interdisciplinary guideline for melanoma. Part 1: diagnostics: update 2022. Eur J Cancer 2022; 170: 236-55.
21.
Atkins MB, Curiel-Lewandrowski C, Fisher DE, et al. The state of melanoma: emergent challenges and opportunities. Clin Cancer Res 2021; 27: 2678-97.
22.
Garbe C, Amaral T, Peris K, et al. European consensus-based interdisciplinary guideline for melanoma. Part 2: treatment - update 2022. Eur J Cancer 2022; 170: 256-84.
23.
Nakamura Y, Asai J, Igaki H, et al. Japanese Dermatological Association guidelines: outlines of guidelines for cutaneous melanoma 2019. J Dermatol 2020; 47: 89-103.
24.
Morawik I, Gospodarek M, Turżańska K, et al. The role of the perioperative nursing care in the satisfaction of patients after large joint replacements. Wiad Lek 2020; 73: 1824-8.
25.
Thayaparan AJ, Mahdi E. The Patient Satisfaction Questionnaire Short Form (PSQ-18) as an adaptable, reliable, and validated tool for use in various settings. Med Educ Online 2013; 18: 21747.
26.
Liang H, Xue Y, Zhang ZR. Patient satisfaction in China: a national survey of inpatients and outpatients. BMJ Open 2021; 11: e049570.
27.
Weber DJ, Anderson D, Rutala WA. The role of the surface environment in healthcare-associated infections. Curr Opin Infect Dis 2013; 26: 338-44.
28.
Mohammmed Iddrisu S, Hutchinson AF, Sungkar Y, Considine J. Nurses’ role in recognising and responding to clinical deterioration in surgical patients. J Clin Nurs 2018; 27: 1920-30.
29.
Weimann A, Braga M, Carli F, et al. ESPEN guideline: clinical nutrition in surgery. Clin Nutr 2017; 36: 623-50.
30.
Lorkowski J, Jugowicz A. Shortage of physicians: a critical review. Adv Exp Med Biol 2021; 1324: 57-62.
31.
Lang-Rollin I, Berberich G. Psycho-oncology. Dialogues Clin Neurosci 2018; 20: 13-22.
32.
Zafar SY, Alexander SC, Weinfurt KP, et al. Decision making and quality of life in the treatment of cancer: a review. Support Care Cancer 2009; 17: 117-27.
33.
Di Maio M, Basch E, Denis F, et al. The role of patient-reported outcome measures in the continuum of cancer clinical care: ESMO Clinical Practice Guideline. Ann Oncol 2022; 33: 878-92.
